Stephen L George, PhD
Principal Investigator, Core B Director
Professor of Biostatistics and Bioinformatics
stephen.george@duke.edu
Duke Personal
Phone: (919) 681-2224
Duke University School of Medicine

Department of Biostatistics and Bioinformatics
2424 Erwin Road, Suite 802, Room 8037
Durham, NC 27705-3833

Dr. George is Professor of Biostatistics and Bioinformatics at Duke and Director of Biostatistics for the Duke Comprehensive Cancer Center (DCCC) and for the CALGB. His expertise is in clinical trials, translational science, and prognostic and predictive models. He is an elected Fellow of the ASA.
Book
Cancer clinical trials: Current and controversial issues in design and analysis., George SL, Wang X, Pang H, Boca Raton, (2016)
Book Chapter
Endpoints for cancer clinical trials., George SL, Wang X, Pang H, Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis, Boca Raton, (2016)
Research methods for clinical trials in personalized medicine: A systematic review., Ren Z, Davidian M, George SL, Goldberg RM, Wright FA, Tsiatis AA, Kosorok MR, Lost In Translation: Barriers to Incentives for Translational Research in Medical Sciences, Singapore, (2014)
Targeted cancer clinical trials., George SL, Wang X, Designs for Clinical Trials, New York, p.157-177. (2012)
Design of phase III clinical trials., George SL, Oncology Clinical Trials: Successful Design, Conduct, and Analysis, New York, (2010)
Software
odsroc: Nonparametric estimation of AUC and partial AUC under test-result-dependent sampling (R)., Wang X, Ma J, George SL, Zhou H, (2012)
permGPU: Using graphics processing units in RNA microarray association studies (CUDA)., Shterev ID, Jung SH, George SL, Owzar K, (2011)
Web Article
Enriched biomarker-driven clinical trials., Wang X, Cai J, George SL, Wiley StatsRef: Statistics Reference Online, (2019)
Sorting the wheat from the chaff: How do we know which cancer therapies really work? , George SL, (2013)